RecruitingPhase 1NCT05003388

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Multiple Sclerosis


Sponsor

The Foundation for Orthopaedics and Regenerative Medicine

Enrollment

15 participants

Start Date

Jun 26, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of multiple sclerosis


Eligibility

Plain Language Summary

Simplified for easier understanding

This study tests stem cells derived from umbilical cord tissue as a potential treatment for Multiple Sclerosis (MS), an autoimmune disease where the immune system attacks the protective coating around nerve fibers. These cells are donated from adult umbilical cords and are not from embryos. **You may be eligible if...** - You have a confirmed diagnosis of Multiple Sclerosis - You are willing and able to sign an informed consent form **You may NOT be eligible if...** - You have an active infection - You have active cancer - You are pregnant - You have had a previous organ transplant - You have serious organ failure or significant lab abnormalities - You are a pre-menopausal woman not using contraception - You have an allergy to sulfur Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells


Locations(2)

Medical Surgical Associates Center

St John's, Antigua and Barbuda

Athens Beverly Hills Medical Group

Glyfada, Athens, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05003388


Related Trials